Edinburgh Clinical Trials

PREdiCCt

The PRognostic effect of Environmental factors in Crohn’s and Colitis.

This is a major study that is now being launched.  This is the first study of its kind and is specifically directed toward understanding how environmental factors and the gut microorganisms influence IBD flare and recovery. For the PREdiCCt study we hope to recruit 1500 people in remission from Crohn’s disease or ulcerative colitis (illness under control) from 28 inflammatory bowel disease clinics across the UK.

 

PREDICCT logo

Chief Investigator: Dr Charlie Lees

Number and location of participating sites (by region/ country): UK, 20-25 sites (anticipated)

ISRCTN number: ISRCTN67248113

 

Funders: Chief Scientist Office (Scottish Government), Cure Crohn’s and Colitis, Crohn’s and colitis in childhood, Edinburgh and Lothian Health Fund

Start and End date

Of grant award: Nov 2016 - Nov 2019

 

Current status: Recruitment complete - in follow up    

 

Website: www.predicct.co.uk

PREdiCCt poster:

 

GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with GDPR, please read this document.

 

Sponsor: University of Edinburgh/NHS Lothian (ACCORD) http://www.accord.ed.ac.uk/

Chief Investigator: Dr Charlie Lees (CI), Gastroenterology department, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU. Charlie.Lees@ed.ac.uk

Trial manager: Lisa Derr    Email: predicct@ed.ac.uk

 

ECTU involvement: Trial Management, Statistics, Database, Data management

(UKCRC)